Pacer Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $250M | Buy |
|
|||||
|
2025
Q2 | $234M | Buy |
|
|||||
|
2025
Q1 | $258M | Buy |
|
|||||
|
2024
Q4 | $12.1M | Sell |
|
|||||
|
2024
Q3 | $20.5M | Buy |
|
|||||
|
2024
Q2 | $17.3M | Buy |
|
|||||
|
2024
Q1 | $14.5M | Buy |
|
|||||
|
2023
Q4 | $12.4M | Buy |
|
|||||
|
2023
Q3 | $10.1M | Buy |
|
|||||
|
2023
Q2 | $7.67M | Sell |
|
|||||
|
2023
Q1 | $10.7M | Buy |
|
|||||
|
2022
Q4 | $4.49M | Sell |
|
|||||
|
2022
Q3 | $181M | Buy |
|
|||||
|
2022
Q2 | $130M | Buy |
|
|||||
|
2022
Q1 | $87.6M | Buy |
|
|||||
|
2021
Q4 | $31M | Buy |
|
|||||
|
2021
Q3 | $6.12M | Sell |
|
|||||
|
2021
Q2 | $5.9M | Buy |
|
|||||
|
2021
Q1 | $4.77M | Sell |
|
|||||
|
2020
Q4 | $5.13M | Sell |
|
|||||
|
2020
Q3 | $8.86M | Sell |
|
|||||
|
2020
Q2 | $10.8M | Buy |
|
|||||
|
2020
Q1 | $4.98M | Buy |
|
|||||
|
2019
Q4 | $3.19M | Sell |
|
|||||
|
2019
Q3 | $8.23M | Buy |
|
|||||
|
2019
Q2 | $8.52M | Buy |
|
|||||
|
2019
Q1 | $5.35M | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $3.65M | Buy |
|
|||||
|
2018
Q2 | $2.43M | Buy |
|
|||||
|
2018
Q1 | $1.99M | Buy |
|
|||||
|
2017
Q4 | $1.84M | Buy |
|
|||||
|
2017
Q3 | $1.51M | Buy |
|
|||||
|
2017
Q2 | $1.45M | Buy |
|
|||||
|
2017
Q1 | $1M | Buy |
|
|||||
|
2016
Q4 | $906K | Sell |
|
|||||
|
2016
Q3 | $1.01M | Sell |
|
|||||
|
2016
Q2 | $916K | Sell |
|
|||||
|
2016
Q1 | $970K | Buy |
|
|||||
|
2015
Q4 | $1.41M | Buy |
|